Company registration number 11801577 (England and Wales)
RESPIROCLEAN LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
RESPIROCLEAN LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
RESPIROCLEAN LTD
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
53,034
48,948
Tangible assets
4
9,508
15,479
62,542
64,427
Current assets
Stocks
16,946
3,406
Debtors
5
129,017
86,037
Cash at bank and in hand
69,437
77,618
215,400
167,061
Creditors: amounts falling due within one year
6
(22,586)
(19,499)
Net current assets
192,814
147,562
Total assets less current liabilities
255,356
211,989
Creditors: amounts falling due after more than one year
7
-
0
(3,500)
Net assets
255,356
208,489
Capital and reserves
Called up share capital
8
80,443
80,443
Profit and loss reserves
174,913
128,046
Total equity
255,356
208,489
RESPIROCLEAN LTD
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 26 February 2026 and are signed on its behalf by:
Mrs A Denneny
Director
Company registration number 11801577 (England and Wales)
RESPIROCLEAN LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Respiroclean Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Mentor House, Ainsworth Street, Blackburn, Lancashire, BB1 6AY.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

RESPIROCLEAN LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
5% straight line
Development costs
20% straight line
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20% straight line
Fixtures and fittings
33.3% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

RESPIROCLEAN LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.9
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.10
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

RESPIROCLEAN LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 6 -
1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
3
3
Intangible fixed assets
Other
£
Cost
At 1 January 2025
135,894
Additions
16,538
At 31 December 2025
152,432
Amortisation and impairment
At 1 January 2025
86,946
Amortisation charged for the year
12,452
At 31 December 2025
99,398
Carrying amount
At 31 December 2025
53,034
At 31 December 2024
48,948
RESPIROCLEAN LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2025
156,807
Additions
6,051
At 31 December 2025
162,858
Depreciation and impairment
At 1 January 2025
141,328
Depreciation charged in the year
12,022
At 31 December 2025
153,350
Carrying amount
At 31 December 2025
9,508
At 31 December 2024
15,479
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
80,300
74,988
Other debtors
48,717
11,049
129,017
86,037

Included within other debtors is a unsecured loan on which interest is charged of £47,477, owed from the directors.

6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
3,500
8,400
Trade creditors
480
1,874
Taxation and social security
5,877
4,435
Other creditors
12,729
4,790
22,586
19,499
RESPIROCLEAN LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
-
0
3,500

The bank loan is a loan provided under the bounce back loan scheme secured by the government.

8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
80,443
80,443
80,443
80,443
2025-12-31 2025-01-01 false false false 26 February 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr R Denneny Mrs A Denneny 11801577 2025-01-01 2025-12-31 11801577 2025-12-31 11801577 2024-12-31 11801577 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 11801577 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 11801577 core:OtherPropertyPlantEquipment 2025-12-31 11801577 core:OtherPropertyPlantEquipment 2024-12-31 11801577 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 11801577 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 11801577 core:Non-currentFinancialInstruments core:AfterOneYear 2025-12-31 11801577 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 11801577 core:CurrentFinancialInstruments 2025-12-31 11801577 core:CurrentFinancialInstruments 2024-12-31 11801577 core:ShareCapital 2025-12-31 11801577 core:ShareCapital 2024-12-31 11801577 core:RetainedEarningsAccumulatedLosses 2025-12-31 11801577 core:RetainedEarningsAccumulatedLosses 2024-12-31 11801577 core:ShareCapitalOrdinaryShareClass1 2025-12-31 11801577 core:ShareCapitalOrdinaryShareClass1 2024-12-31 11801577 bus:Director2 2025-01-01 2025-12-31 11801577 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 11801577 core:PatentsTrademarksLicencesConcessionsSimilar 2025-01-01 2025-12-31 11801577 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 11801577 core:PlantMachinery 2025-01-01 2025-12-31 11801577 core:FurnitureFittings 2025-01-01 2025-12-31 11801577 2024-01-01 2024-12-31 11801577 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 11801577 core:OtherPropertyPlantEquipment 2024-12-31 11801577 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 11801577 core:Non-currentFinancialInstruments 2025-12-31 11801577 core:Non-currentFinancialInstruments 2024-12-31 11801577 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 11801577 bus:OrdinaryShareClass1 2025-12-31 11801577 bus:OrdinaryShareClass1 2024-12-31 11801577 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 11801577 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 11801577 bus:FRS102 2025-01-01 2025-12-31 11801577 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 11801577 bus:Director1 2025-01-01 2025-12-31 11801577 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP